A-674563 | Interleukin Related interleukin-related.com

Product Name :
A-674563

Search keywords :
A-674563

drugId :
null

Target Vo:
Serine/threonine-protein kinase AKT1

Target Vo Short Name :
AKT1

Moa_Name:
Tyrosine-protein kinase receptor FLT3 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Hefei Cosource Medicine Technology

Active Company_Name :
Hefei Cosource Medicine Technology

Active Indication_Name:
Leukemia, Myeloid, Acute

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:
Preclinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Histone H4 (acetyl K16) Antibody
Fatty Acid Synthase Antibody
Erk1 (pT202/pY204)+Erk2 (pT185/pY187) Antibody (YA455): Erk1 (pT202/pY204)+Erk2 (pT185/pY187) Antibody (YA455) is a non-conjugated and Rabbit origined monoclonal antibody about 41/43 kDa, targeting to Erk1 (pT202/pY204) + Erk2 (pT185/pY187). It can be used for WB,IP,IHC-P assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts